Drug Discovery
Use Case Family
Business Domain
R&D
Processes
Drug Discovery and Preclinical Research
Challenge
Traditional drug discovery is time-intensive, expensive, and prone to inaccurate predictions. Identifying effective compounds using standard methods often delays innovation and elevates risks in clinical phases.
Solution
Generative AI enables fast and accurate simulation of novel compounds with therapeutic potential. By learning from molecular data, it proposes new structures similar to known drugs, accelerating discovery while cutting costs and lab time.
Benefits
-
Accelerates drug candidate discovery
-
Reduces development costs and trial redundancies
-
Improves accuracy of efficacy and safety predictions
Target Group
Potential Industries
Risk Classification (EU AI Act)
Limited Risk systems
Art. 50
with Transparency Obligations according Art. 50 EU AI Act